Trading a BBP straddle lets you take a pure volatility position on Virtus Biotech ETF without committing to a direction. Virtus Biotech ETF's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate BBP straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on BBP profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Virtus Biotech ETF stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the BBP straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Products ETF to Virtus Biotech ETF.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the BBP straddle is the cleanest expression of that view. Our scanner prices every BBP straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a BBP straddle into a catalyst or short a BBP straddle to harvest decay, the options straddle setups that matter are all in one place.
